Elevance Health Net Income/Loss 2010-2025 | ELV

Elevance Health net income/loss for the twelve months ending March 31, 2025 was $18.263B, a 5.81% increase year-over-year.

  • Elevance Health annual net income/loss for 2024 was $5.971B, a 0.33% decline from 2023.
  • Elevance Health annual net income/loss for 2023 was $5.991B, a 1.75% increase from 2022.
  • Elevance Health annual net income/loss for 2022 was $5.888B, a 4.24% decline from 2021.

Elevance Health Net Income/Loss 2010-2025 | ELV

  • Elevance Health annual net income/loss for 2024 was $5.971B, a 0.33% decline from 2023.
  • Elevance Health annual net income/loss for 2023 was $5.991B, a 1.75% increase from 2022.
  • Elevance Health annual net income/loss for 2022 was $5.888B, a 4.24% decline from 2021.
Related Stocks
Company NameMarket
Cap
Danaher (DHR)$134.6B
CVS Health (CVS)$78B
Cencora (COR)$56.7B
DiDi Global (DIDIY)$26.2B
Labcorp Holdings (LH)$20.3B
Natera (NTRA)$19.2B
BioMerieux (BMXMF)$16.3B
EUROFINS SCIENT (ERFSF)$13.9B
CochLear (CHEOY)$13B
Solventum (SOLV)$12.5B
ICON (ICLR)$11.3B
Revvity (RVTY)$10.7B
Viatris (VTRS)$10.4B
Medpace Holdings (MEDP)$8.9B
Sonic Healthcare (SKHHY)$8.8B
Avantor (AVTR)$8.4B
HealthEquity (HQY)$8.4B
Charles River Laboratories (CRL)$7.4B
Caris Life Sciences,�Inc (CAI)$7.2B
Amplifon S.p.A (AMFPF)$5.4B
Bausch + Lomb (BLCO)$4.9B
BrightSpring Health Services (BTSG)$3.5B
Sotera Health (SHC)$3.1B
Surgery Partners (SGRY)$2.9B
Concentras Parent (CON)$2.6B
Alignment Healthcare (ALHC)$2.5B
Organon (OGN)$2.5B
GeneDx Holdings (WGS)$2.2B
Progyny (PGNY)$2B
PACS (PACS)$1.8B